Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies
about
Therapies for Prevention and Treatment of Alzheimer's DiseaseConfocal Spectroscopy to Study Dimerization, Oligomerization and Aggregation of Proteins: A Practical GuideNeuronal Gene Targets of NF-κB and Their Dysregulation in Alzheimer's DiseaseGlial contributions to neurodegeneration in tauopathies.Monoaminergic neuropathology in Alzheimer's disease.Potential mechanisms and implications for the formation of tau oligomeric strains.Biomarkers of Traumatic Brain Injury: Temporal Changes in Body FluidsNew Opportunities and Challenges of Smart Polymers in Post-Translational Modification Proteomics.Design and Development of a Novel Chalcone Derivative as an Anticholinesterase Inhibitor for Possible Treatment of Dementia.Comparative pathobiology of β-amyloid and the unique susceptibility of humans to Alzheimer's diseaseAugmenting autophagy for prognosis based intervention of COPD-pathophysiology.Perspective Insights of Exosomes in Neurodegenerative Diseases: A Critical Appraisal.Rebalancing β-Amyloid-Induced Decrease of ATP Level by Amorphous Nano/Micro Polyphosphate: Suppression of the Neurotoxic Effect of Amyloid β-Protein Fragment 25-35.Potentiating tangle formation reduces acute toxicity of soluble tau species in the rat.Master Autophagy Regulator Transcription Factor EB Regulates Cigarette Smoke-Induced Autophagy Impairment and Chronic Obstructive Pulmonary Disease-Emphysema Pathogenesis.Receptor for advanced glycation end products mediates sepsis-triggered amyloid-β accumulation, Tau phosphorylation, and cognitive impairment.Oxygen and Glucose Deprivation Alter Synaptic Distribution of Tau Protein: The Role of Phosphorylation.A Single Neonatal Exposure to BMAA in a Rat Model Produces Neuropathology Consistent with Neurodegenerative Diseases.Small-molecule PET Tracers for Imaging Proteinopathies.Understanding Miro GTPases: Implications in the Treatment of Neurodegenerative Disorders.EuroTau: towing scientists to tau without tautology.Kidins220 Correlates with Tau in Alzheimer's Disease Brain and Cerebrospinal Fluid.Tau Proteolysis in the Pathogenesis of Tauopathies: Neurotoxic Fragments and Novel Biomarkers.Tau protein liquid-liquid phase separation can initiate tau aggregation.Comparing the Folds of Prions and Other Pathogenic Amyloids.The novel histone de acetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer's disease model.Neuroprotection Targeting Protein Misfolding on Chronic Cerebral Hypoperfusion in the Context of Metabolic Syndrome.Phosphorylation of different tau sites during progression of Alzheimer's disease.A bispecific immunotweezer prevents soluble PrP oligomers and abolishes prion toxicityMinimotifs dysfunction is pervasive in neurodegenerative disordersA Closer Look into the Role of Protein Tau in the Identification of Promising Therapeutic Targets for Alzheimer's DiseaseInflammation as a central mechanism in Alzheimer's diseaseIntegration of Biomarkers Into a Signature Profile of Persistent Traumatic Brain Injury Involving Autoimmune Processes Following Water Hammer Injury From Repetitive Head ImpactsNovel Protein Kinase Inhibitors Related to Tau Pathology Modulate Tau Protein-Self Interaction Using a Luciferase Complementation Assay
P2860
Q26740007-737BEB0D-8614-4485-A631-FC5695CBF8CBQ26752808-458A7BCA-0BAC-4A15-9088-43B4EA314845Q28074504-70C6A4E4-F94F-4778-AB29-2DBC713F5ECCQ32173558-3EA582D2-96D1-4591-9002-2193AC75C63CQ38809649-E7C102BB-2593-4C36-8835-8433A524A1E0Q38960046-3E20DE93-B20A-4E29-AF9B-D7997CA55D63Q39061827-B82B38AF-430E-4E24-8237-C692DAF7D4DFQ39098842-6BDA6AF5-FA31-4105-A3A4-DC053446973AQ41036141-D8CE1435-C7F0-4D77-ACA4-28D6A8714A3BQ41971448-B4427A3C-06BC-4295-B575-FB8C39DF8A0AQ42354703-F2D087CE-A1BF-4C98-8ECD-20900406E0BFQ42369812-F1A54BED-8289-4FCE-A0B5-EE6B0FDD857AQ43227037-B6ECC00E-4C95-4ED8-A743-C2E82405A312Q46237544-90FF4436-A899-45EE-AB90-32FB3F5F012CQ46460982-DF00A268-CA21-48FE-8C70-304862407DCBQ47414857-25FD6CFD-6376-4E60-87D7-EF22E08362FFQ47860725-9FF19CA9-AEC9-4706-87E4-48CA733F7BE6Q47891276-479DBF98-CF82-486D-9A89-081AA86E240BQ47926474-899A8EA1-5264-4221-87FF-EA7E04AD8235Q48092663-F2D966DF-40B0-45AB-851D-943A147408E2Q48215823-C1042253-A401-479A-BBA4-A2727A414778Q48425790-D6CC6826-A990-4132-9616-3D8E512FC28DQ52598834-0240C2F5-E7BC-416C-86A1-17D8D2CE3413Q53395943-D1063B2B-FA99-4542-ADCD-F451272AE79FQ53397941-9AC3A6D4-D5A2-4E36-BD29-C56F732D4F65Q54977801-3483E264-DACB-4CC8-B19B-8F4EFDFD4A01Q55109555-F8C5F3BE-23B7-40E5-AABB-69B9FDCC2E97Q55517090-D0CDDD5C-26A2-448B-903B-F890B954F104Q57061905-B45C8F02-FE05-40C8-A129-2A873B120D91Q57174649-145E0120-9140-4A9E-AEC1-2A284D1EBB68Q57927766-DFE23C2E-0D09-4954-86B2-4C5171B9E900Q58555818-55637E7D-635D-4785-9FE3-1CE3E413932FQ58596203-26C1D6DA-722D-4EAE-828D-E332F72B85D0Q58696563-BC476691-62DB-45C3-81A1-9DD9FDE0BF94
P2860
Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies
description
2016 nî lūn-bûn
@nan
2016 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Tau Protein Hyperphosphorylati ...... ble Neuroprotective Strategies
@ast
Tau Protein Hyperphosphorylati ...... ble Neuroprotective Strategies
@en
Tau Protein Hyperphosphorylati ...... ble Neuroprotective Strategies
@nl
type
label
Tau Protein Hyperphosphorylati ...... ble Neuroprotective Strategies
@ast
Tau Protein Hyperphosphorylati ...... ble Neuroprotective Strategies
@en
Tau Protein Hyperphosphorylati ...... ble Neuroprotective Strategies
@nl
prefLabel
Tau Protein Hyperphosphorylati ...... ble Neuroprotective Strategies
@ast
Tau Protein Hyperphosphorylati ...... ble Neuroprotective Strategies
@en
Tau Protein Hyperphosphorylati ...... ble Neuroprotective Strategies
@nl
P2093
P2860
P50
P921
P3181
P356
P1433
P1476
Tau Protein Hyperphosphorylati ...... ble Neuroprotective Strategies
@en
P2093
Claude Wischik
Danira Bažadona
Patrick R Hof
Rohan de Silva
Selina Wray
P2860
P3181
P356
10.3390/BIOM6010006
P407
P50
P5008
P577
2016-01-06T00:00:00Z